Antibacterial Drug Resistance Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0087258
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:7.34
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 7.34 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
The global Antibacterial Drug Resistance market is valued at million US$ in 2018 and will reach million US$ by the end of 2026, growing at a CAGR of during 2019-2026. The objectives of this study are to define, segment, and project the size of the Antibacterial Drug Resistance market based on company, product type, end user and key regions.This report studies the global market size of Antibacterial Drug Resistance in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibacterial Drug Resistance in these regions.
This research report categorizes the global Antibacterial Drug Resistance market by top players/brands, region, type and end user. This report also studies the global Antibacterial Drug Resistance market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AAIPharma Services
ANTABIO
Abgentis
Abbott Laboratories
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
GSK
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
PENDOPHARM
Pfizer
VenatoRx Pharmaceuticals
Market size by Product
Telavancin (Vibativ)
Ceftaroline Fosamil (Teflaro/ Zinforo)
Fidaxomicin (Dificid / Dificlir)
Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Dalbavancin (Dalvance/ Xydalba)
Tedizolid Phosphate (Sivextro)
Oritavancin (Orbactiv/ Nuvocid)
Ceftolozane-Tazobactam (Zerbaxa)
Ceftazidime-Avibactam (Avycaz/ Zavicefta)
PHASE III DRUGS
Market size by End User
Gram-Positive
Gram-Negative
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antibacterial Drug Resistance market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2026.
To understand the structure of Antibacterial Drug Resistance market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antibacterial Drug Resistance companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antibacterial Drug Resistance submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antibacterial Drug Resistance are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibacterial Drug Resistance market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Antibacterial Drug Resistance Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibacterial Drug Resistance Market Size Growth Rate by Product
1.4.2 Telavancin (Vibativ)
1.4.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
1.4.4 Fidaxomicin (Dificid / Dificlir)
1.4.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
1.4.6 Dalbavancin (Dalvance/ Xydalba)
1.4.7 Tedizolid Phosphate (Sivextro)
1.4.8 Oritavancin (Orbactiv/ Nuvocid)
1.4.9 Ceftolozane-Tazobactam (Zerbaxa)
1.4.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
1.4.11 PHASE III DRUGS
1.5 Market by End User
1.5.1 Global Antibacterial Drug Resistance Market Size Growth Rate by End User
1.5.2 Gram-Positive
1.5.3 Gram-Negative
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibacterial Drug Resistance Market Size
2.1.1 Global Antibacterial Drug Resistance Revenue 2014-2025
2.1.2 Global Antibacterial Drug Resistance Sales 2014-2025
2.2 Antibacterial Drug Resistance Growth Rate by Regions
2.2.1 Global Antibacterial Drug Resistance Sales by Regions
2.2.2 Global Antibacterial Drug Resistance Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibacterial Drug Resistance Sales by Manufacturers
3.1.1 Antibacterial Drug Resistance Sales by Manufacturers
3.1.2 Antibacterial Drug Resistance Sales Market Share by Manufacturers
3.1.3 Global Antibacterial Drug Resistance Market Concentration Ratio (CR5 and HHI)
3.2 Antibacterial Drug Resistance Revenue by Manufacturers
3.2.1 Antibacterial Drug Resistance Revenue by Manufacturers (2014-2019)
3.2.2 Antibacterial Drug Resistance Revenue Share by Manufacturers (2014-2019)
3.3 Antibacterial Drug Resistance Price by Manufacturers
3.4 Antibacterial Drug Resistance Manufacturing Base Distribution, Product Types
3.4.1 Antibacterial Drug Resistance Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibacterial Drug Resistance Product Type
3.4.3 Date of International Manufacturers Enter into Antibacterial Drug Resistance Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antibacterial Drug Resistance Sales by Product
4.2 Global Antibacterial Drug Resistance Revenue by Product
4.3 Antibacterial Drug Resistance Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibacterial Drug Resistance Breakdown Data by End User
6 North America
6.1 North America Antibacterial Drug Resistance by Countries
6.1.1 North America Antibacterial Drug Resistance Sales by Countries
6.1.2 North America Antibacterial Drug Resistance Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibacterial Drug Resistance by Product
6.3 North America Antibacterial Drug Resistance by End User
7 Europe
7.1 Europe Antibacterial Drug Resistance by Countries
7.1.1 Europe Antibacterial Drug Resistance Sales by Countries
7.1.2 Europe Antibacterial Drug Resistance Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibacterial Drug Resistance by Product
7.3 Europe Antibacterial Drug Resistance by End User
8 Asia Pacific
8.1 Asia Pacific Antibacterial Drug Resistance by Countries
8.1.1 Asia Pacific Antibacterial Drug Resistance Sales by Countries
8.1.2 Asia Pacific Antibacterial Drug Resistance Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibacterial Drug Resistance by Product
8.3 Asia Pacific Antibacterial Drug Resistance by End User
9 Central & South America
9.1 Central & South America Antibacterial Drug Resistance by Countries
9.1.1 Central & South America Antibacterial Drug Resistance Sales by Countries
9.1.2 Central & South America Antibacterial Drug Resistance Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibacterial Drug Resistance by Product
9.3 Central & South America Antibacterial Drug Resistance by End User
10 Middle East and Africa
10.1 Middle East and Africa Antibacterial Drug Resistance by Countries
10.1.1 Middle East and Africa Antibacterial Drug Resistance Sales by Countries
10.1.2 Middle East and Africa Antibacterial Drug Resistance Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibacterial Drug Resistance by Product
10.3 Middle East and Africa Antibacterial Drug Resistance by End User
11 Company Profiles
11.1 AAIPharma Services
11.1.1 AAIPharma Services Company Details
11.1.2 Company Business Overview
11.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AAIPharma Services Antibacterial Drug Resistance Products Offered
11.1.5 AAIPharma Services Recent Development
11.2 ANTABIO
11.2.1 ANTABIO Company Details
11.2.2 Company Business Overview
11.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.2.4 ANTABIO Antibacterial Drug Resistance Products Offered
11.2.5 ANTABIO Recent Development
11.3 Abgentis
11.3.1 Abgentis Company Details
11.3.2 Company Business Overview
11.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Abgentis Antibacterial Drug Resistance Products Offered
11.3.5 Abgentis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Laboratories Antibacterial Drug Resistance Products Offered
11.4.5 Abbott Laboratories Recent Development
11.5 Absynth Biologics
11.5.1 Absynth Biologics Company Details
11.5.2 Company Business Overview
11.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Absynth Biologics Antibacterial Drug Resistance Products Offered
11.5.5 Absynth Biologics Recent Development
11.6 Achaogen
11.6.1 Achaogen Company Details
11.6.2 Company Business Overview
11.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Achaogen Antibacterial Drug Resistance Products Offered
11.6.5 Achaogen Recent Development
11.7 Acino Holdings
11.7.1 Acino Holdings Company Details
11.7.2 Company Business Overview
11.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Acino Holdings Antibacterial Drug Resistance Products Offered
11.7.5 Acino Holdings Recent Development
11.8 Aventis Pharma
11.8.1 Aventis Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Aventis Pharma Antibacterial Drug Resistance Products Offered
11.8.5 Aventis Pharma Recent Development
11.9 Austell Laboratories
11.9.1 Austell Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Austell Laboratories Antibacterial Drug Resistance Products Offered
11.9.5 Austell Laboratories Recent Development
11.10 Assembly Biosciences
11.10.1 Assembly Biosciences Company Details
11.10.2 Company Business Overview
11.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Assembly Biosciences Antibacterial Drug Resistance Products Offered
11.10.5 Assembly Biosciences Recent Development
11.11 Arpida
11.12 Demuris
11.13 Evolva Holding
11.14 ContraFect
11.15 Cerexa
11.16 GSK
11.17 InterMune
11.18 Isis Pharmaceuticals
11.19 Lyndra
11.20 Microbecide
11.21 Morphochem
11.22 Nabriva Therapeutics
11.23 NanoSafe Coatings
11.24 Novexel
11.25 Osel
11.26 PENDOPHARM
11.27 Pfizer
11.28 VenatoRx Pharmaceuticals
12 Future Forecast
12.1 Antibacterial Drug Resistance Market Forecast by Regions
12.1.1 Global Antibacterial Drug Resistance Sales Forecast by Regions 2019-2025
12.1.2 Global Antibacterial Drug Resistance Revenue Forecast by Regions 2019-2025
12.2 Antibacterial Drug Resistance Market Forecast by Product
12.2.1 Global Antibacterial Drug Resistance Sales Forecast by Product 2019-2025
12.2.2 Global Antibacterial Drug Resistance Revenue Forecast by Product 2019-2025
12.3 Antibacterial Drug Resistance Market Forecast by End User
12.4 North America Antibacterial Drug Resistance Forecast
12.5 Europe Antibacterial Drug Resistance Forecast
12.6 Asia Pacific Antibacterial Drug Resistance Forecast
12.7 Central & South America Antibacterial Drug Resistance Forecast
12.8 Middle East and Africa Antibacterial Drug Resistance Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibacterial Drug Resistance Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Antibacterial Drug Resistance Product Picture
Table Antibacterial Drug Resistance Market Segments
Table Key Manufacturers Antibacterial Drug Resistance Covered
Table Global Antibacterial Drug Resistance Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antibacterial Drug Resistance Sales Market Share by Product 2014-2025
Figure Telavancin (Vibativ) Product Picture
Table Major Manufacturers of Telavancin (Vibativ)
Figure Ceftaroline Fosamil (Teflaro/ Zinforo) Product Picture
Table Major Manufacturers of Ceftaroline Fosamil (Teflaro/ Zinforo)
Figure Fidaxomicin (Dificid / Dificlir) Product Picture
Table Major Manufacturers of Fidaxomicin (Dificid / Dificlir)
Figure Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Product Picture
Table Major Manufacturers of Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Figure Dalbavancin (Dalvance/ Xydalba) Product Picture
Table Major Manufacturers of Dalbavancin (Dalvance/ Xydalba)
Figure Tedizolid Phosphate (Sivextro) Product Picture
Table Major Manufacturers of Tedizolid Phosphate (Sivextro)
Figure Oritavancin (Orbactiv/ Nuvocid) Product Picture
Table Major Manufacturers of Oritavancin (Orbactiv/ Nuvocid)
Figure Ceftolozane-Tazobactam (Zerbaxa) Product Picture
Table Major Manufacturers of Ceftolozane-Tazobactam (Zerbaxa)
Figure Ceftazidime-Avibactam (Avycaz/ Zavicefta) Product Picture
Table Major Manufacturers of Ceftazidime-Avibactam (Avycaz/ Zavicefta)
Figure PHASE III DRUGS Product Picture
Table Major Manufacturers of PHASE III DRUGS
Table Global Antibacterial Drug Resistance Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Gram-Positive
Figure Gram-Negative
Figure Antibacterial Drug Resistance Report Years Considered
Figure Global Antibacterial Drug Resistance Market Size 2014-2025 (Million US$)
Figure Global Antibacterial Drug Resistance Sales 2014-2025 (K Units)
Table Global Antibacterial Drug Resistance Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antibacterial Drug Resistance Sales by Regions 2014-2019 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share by Regions 2014-2019
Figure Global Antibacterial Drug Resistance Sales Market Share by Regions 2014-2019
Figure 2018 Global Antibacterial Drug Resistance Sales Market Share by Regions
Table Global Antibacterial Drug Resistance Revenue by Regions 2014-2019 (Million US$)
Table Global Antibacterial Drug Resistance Revenue Market Share by Regions 2014-2019
Figure Global Antibacterial Drug Resistance Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antibacterial Drug Resistance Revenue Market Share by Regions
Table Global Antibacterial Drug Resistance Sales by Manufacturers (2014-2019) (K Units)
Table Global Antibacterial Drug Resistance Sales Share by Manufacturers (2014-2019)
Figure Global Antibacterial Drug Resistance Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antibacterial Drug Resistance Revenue by Manufacturers (2014-2019) (Million USD)
Table Antibacterial Drug Resistance Revenue Share by Manufacturers (2014-2019)
Figure Antibacterial Drug Resistance Value Share by Manufacturers in 2018
Table Key Manufacturers Antibacterial Drug Resistance Price (2014-2019) (USD/Unit)
Table Antibacterial Drug Resistance Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antibacterial Drug Resistance Product Type
Table Date of International Manufacturers Enter into Antibacterial Drug Resistance Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Global Antibacterial Drug Resistance Sales Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Sales Market Share by Product in 2018
Table Global Antibacterial Drug Resistance Revenue by Product (2014-2019) (Million US$)
Table Global Antibacterial Drug Resistance Revenue Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Revenue Market Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Revenue Market Share by Product in 2018
Table Antibacterial Drug Resistance Price by Product 2014-2019 (USD/Unit)
Table Global Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Global Antibacterial Drug Resistance Sales Share by End User (2014-2019)
Figure Global Sales Antibacterial Drug Resistance Market Share by End User (2014-2019)
Figure Global Sales Antibacterial Drug Resistance Market Share by End User in 2018
Figure North America Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure North America Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table North America Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Sales Market Share by Countries
Table North America Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table North America Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Revenue Market Share by Countries
Figure United States Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure United States Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table North America Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Market Share by Product
Table North America Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table North America Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Market Share by End User
Figure Europe Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Europe Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Sales Market Share by Countries
Table Europe Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Europe Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Revenue Market Share by Countries
Figure Germany Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure France Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure UK Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Europe Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Market Share by Product
Table Europe Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Europe Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Market Share by End User
Figure Asia Pacific Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Sales Market Share by Countries
Table Asia Pacific Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Revenue Market Share by Countries
Figure China Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure China Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure India Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Market Share by Product
Table Asia Pacific Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Market Share by End User
Figure Central & South America Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Central & South America Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Sales Market Share by Countries
Table Central & South America Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Revenue Market Share by Countries
Figure Brazil Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Central & South America Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Market Share by Product
Table Central & South America Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Central & South America Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Market Share by End User
Figure Middle East and Africa Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Sales Market Share by Countries
Table Middle East and Africa Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Revenue Market Share by Countries
Figure GCC Countries Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Market Share by Product
Table Middle East and Africa Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Market Share by End User
Table AAIPharma Services Company Details
Table AAIPharma Services Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AAIPharma Services Recent Development
Table ANTABIO Company Details
Table ANTABIO Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ANTABIO Recent Development
Table Abgentis Company Details
Table Abgentis Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abgentis Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Absynth Biologics Company Details
Table Absynth Biologics Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Absynth Biologics Recent Development
Table Achaogen Company Details
Table Achaogen Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Achaogen Recent Development
Table Acino Holdings Company Details
Table Acino Holdings Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Acino Holdings Recent Development
Table Aventis Pharma Company Details
Table Aventis Pharma Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aventis Pharma Recent Development
Table Austell Laboratories Company Details
Table Austell Laboratories Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Austell Laboratories Recent Development
Table Assembly Biosciences Company Details
Table Assembly Biosciences Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Assembly Biosciences Recent Development
Table Arpida Company Details
Table Demuris Company Details
Table Evolva Holding Company Details
Table ContraFect Company Details
Table Cerexa Company Details
Table GSK Company Details
Table InterMune Company Details
Table Isis Pharmaceuticals Company Details
Table Lyndra Company Details
Table Microbecide Company Details
Table Morphochem Company Details
Table Nabriva Therapeutics Company Details
Table NanoSafe Coatings Company Details
Table Novexel Company Details
Table Osel Company Details
Table PENDOPHARM Company Details
Table Pfizer Company Details
Table VenatoRx Pharmaceuticals Company Details
Table Global Antibacterial Drug Resistance Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share Forecast by Regions 2019-2025
Table Global Antibacterial Drug Resistance Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antibacterial Drug Resistance Revenue Market Share Forecast by Regions 2019-2025
Table Global Antibacterial Drug Resistance Sales Forecast by Product 2019-2025 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share Forecast by Product 2019-2025
Table Global Antibacterial Drug Resistance Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antibacterial Drug Resistance Revenue Market Share Forecast by Product 2019-2025
Table Global Antibacterial Drug Resistance Sales Forecast by End User 2019-2025 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share Forecast by End User 2019-2025
Figure North America Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antibacterial Drug Resistance Value Chain
Table Antibacterial Drug Resistance Customers List
Table Antibacterial Drug Resistance Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Study Coverage
1.1 Antibacterial Drug Resistance Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibacterial Drug Resistance Market Size Growth Rate by Product
1.4.2 Telavancin (Vibativ)
1.4.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
1.4.4 Fidaxomicin (Dificid / Dificlir)
1.4.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
1.4.6 Dalbavancin (Dalvance/ Xydalba)
1.4.7 Tedizolid Phosphate (Sivextro)
1.4.8 Oritavancin (Orbactiv/ Nuvocid)
1.4.9 Ceftolozane-Tazobactam (Zerbaxa)
1.4.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
1.4.11 PHASE III DRUGS
1.5 Market by End User
1.5.1 Global Antibacterial Drug Resistance Market Size Growth Rate by End User
1.5.2 Gram-Positive
1.5.3 Gram-Negative
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibacterial Drug Resistance Market Size
2.1.1 Global Antibacterial Drug Resistance Revenue 2014-2025
2.1.2 Global Antibacterial Drug Resistance Sales 2014-2025
2.2 Antibacterial Drug Resistance Growth Rate by Regions
2.2.1 Global Antibacterial Drug Resistance Sales by Regions
2.2.2 Global Antibacterial Drug Resistance Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibacterial Drug Resistance Sales by Manufacturers
3.1.1 Antibacterial Drug Resistance Sales by Manufacturers
3.1.2 Antibacterial Drug Resistance Sales Market Share by Manufacturers
3.1.3 Global Antibacterial Drug Resistance Market Concentration Ratio (CR5 and HHI)
3.2 Antibacterial Drug Resistance Revenue by Manufacturers
3.2.1 Antibacterial Drug Resistance Revenue by Manufacturers (2014-2019)
3.2.2 Antibacterial Drug Resistance Revenue Share by Manufacturers (2014-2019)
3.3 Antibacterial Drug Resistance Price by Manufacturers
3.4 Antibacterial Drug Resistance Manufacturing Base Distribution, Product Types
3.4.1 Antibacterial Drug Resistance Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibacterial Drug Resistance Product Type
3.4.3 Date of International Manufacturers Enter into Antibacterial Drug Resistance Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antibacterial Drug Resistance Sales by Product
4.2 Global Antibacterial Drug Resistance Revenue by Product
4.3 Antibacterial Drug Resistance Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibacterial Drug Resistance Breakdown Data by End User
6 North America
6.1 North America Antibacterial Drug Resistance by Countries
6.1.1 North America Antibacterial Drug Resistance Sales by Countries
6.1.2 North America Antibacterial Drug Resistance Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibacterial Drug Resistance by Product
6.3 North America Antibacterial Drug Resistance by End User
7 Europe
7.1 Europe Antibacterial Drug Resistance by Countries
7.1.1 Europe Antibacterial Drug Resistance Sales by Countries
7.1.2 Europe Antibacterial Drug Resistance Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibacterial Drug Resistance by Product
7.3 Europe Antibacterial Drug Resistance by End User
8 Asia Pacific
8.1 Asia Pacific Antibacterial Drug Resistance by Countries
8.1.1 Asia Pacific Antibacterial Drug Resistance Sales by Countries
8.1.2 Asia Pacific Antibacterial Drug Resistance Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibacterial Drug Resistance by Product
8.3 Asia Pacific Antibacterial Drug Resistance by End User
9 Central & South America
9.1 Central & South America Antibacterial Drug Resistance by Countries
9.1.1 Central & South America Antibacterial Drug Resistance Sales by Countries
9.1.2 Central & South America Antibacterial Drug Resistance Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibacterial Drug Resistance by Product
9.3 Central & South America Antibacterial Drug Resistance by End User
10 Middle East and Africa
10.1 Middle East and Africa Antibacterial Drug Resistance by Countries
10.1.1 Middle East and Africa Antibacterial Drug Resistance Sales by Countries
10.1.2 Middle East and Africa Antibacterial Drug Resistance Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibacterial Drug Resistance by Product
10.3 Middle East and Africa Antibacterial Drug Resistance by End User
11 Company Profiles
11.1 AAIPharma Services
11.1.1 AAIPharma Services Company Details
11.1.2 Company Business Overview
11.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AAIPharma Services Antibacterial Drug Resistance Products Offered
11.1.5 AAIPharma Services Recent Development
11.2 ANTABIO
11.2.1 ANTABIO Company Details
11.2.2 Company Business Overview
11.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.2.4 ANTABIO Antibacterial Drug Resistance Products Offered
11.2.5 ANTABIO Recent Development
11.3 Abgentis
11.3.1 Abgentis Company Details
11.3.2 Company Business Overview
11.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Abgentis Antibacterial Drug Resistance Products Offered
11.3.5 Abgentis Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Laboratories Antibacterial Drug Resistance Products Offered
11.4.5 Abbott Laboratories Recent Development
11.5 Absynth Biologics
11.5.1 Absynth Biologics Company Details
11.5.2 Company Business Overview
11.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Absynth Biologics Antibacterial Drug Resistance Products Offered
11.5.5 Absynth Biologics Recent Development
11.6 Achaogen
11.6.1 Achaogen Company Details
11.6.2 Company Business Overview
11.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Achaogen Antibacterial Drug Resistance Products Offered
11.6.5 Achaogen Recent Development
11.7 Acino Holdings
11.7.1 Acino Holdings Company Details
11.7.2 Company Business Overview
11.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Acino Holdings Antibacterial Drug Resistance Products Offered
11.7.5 Acino Holdings Recent Development
11.8 Aventis Pharma
11.8.1 Aventis Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Aventis Pharma Antibacterial Drug Resistance Products Offered
11.8.5 Aventis Pharma Recent Development
11.9 Austell Laboratories
11.9.1 Austell Laboratories Company Details
11.9.2 Company Business Overview
11.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Austell Laboratories Antibacterial Drug Resistance Products Offered
11.9.5 Austell Laboratories Recent Development
11.10 Assembly Biosciences
11.10.1 Assembly Biosciences Company Details
11.10.2 Company Business Overview
11.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Assembly Biosciences Antibacterial Drug Resistance Products Offered
11.10.5 Assembly Biosciences Recent Development
11.11 Arpida
11.12 Demuris
11.13 Evolva Holding
11.14 ContraFect
11.15 Cerexa
11.16 GSK
11.17 InterMune
11.18 Isis Pharmaceuticals
11.19 Lyndra
11.20 Microbecide
11.21 Morphochem
11.22 Nabriva Therapeutics
11.23 NanoSafe Coatings
11.24 Novexel
11.25 Osel
11.26 PENDOPHARM
11.27 Pfizer
11.28 VenatoRx Pharmaceuticals
12 Future Forecast
12.1 Antibacterial Drug Resistance Market Forecast by Regions
12.1.1 Global Antibacterial Drug Resistance Sales Forecast by Regions 2019-2025
12.1.2 Global Antibacterial Drug Resistance Revenue Forecast by Regions 2019-2025
12.2 Antibacterial Drug Resistance Market Forecast by Product
12.2.1 Global Antibacterial Drug Resistance Sales Forecast by Product 2019-2025
12.2.2 Global Antibacterial Drug Resistance Revenue Forecast by Product 2019-2025
12.3 Antibacterial Drug Resistance Market Forecast by End User
12.4 North America Antibacterial Drug Resistance Forecast
12.5 Europe Antibacterial Drug Resistance Forecast
12.6 Asia Pacific Antibacterial Drug Resistance Forecast
12.7 Central & South America Antibacterial Drug Resistance Forecast
12.8 Middle East and Africa Antibacterial Drug Resistance Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibacterial Drug Resistance Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Antibacterial Drug Resistance Product Picture
Table Antibacterial Drug Resistance Market Segments
Table Key Manufacturers Antibacterial Drug Resistance Covered
Table Global Antibacterial Drug Resistance Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antibacterial Drug Resistance Sales Market Share by Product 2014-2025
Figure Telavancin (Vibativ) Product Picture
Table Major Manufacturers of Telavancin (Vibativ)
Figure Ceftaroline Fosamil (Teflaro/ Zinforo) Product Picture
Table Major Manufacturers of Ceftaroline Fosamil (Teflaro/ Zinforo)
Figure Fidaxomicin (Dificid / Dificlir) Product Picture
Table Major Manufacturers of Fidaxomicin (Dificid / Dificlir)
Figure Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Product Picture
Table Major Manufacturers of Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Figure Dalbavancin (Dalvance/ Xydalba) Product Picture
Table Major Manufacturers of Dalbavancin (Dalvance/ Xydalba)
Figure Tedizolid Phosphate (Sivextro) Product Picture
Table Major Manufacturers of Tedizolid Phosphate (Sivextro)
Figure Oritavancin (Orbactiv/ Nuvocid) Product Picture
Table Major Manufacturers of Oritavancin (Orbactiv/ Nuvocid)
Figure Ceftolozane-Tazobactam (Zerbaxa) Product Picture
Table Major Manufacturers of Ceftolozane-Tazobactam (Zerbaxa)
Figure Ceftazidime-Avibactam (Avycaz/ Zavicefta) Product Picture
Table Major Manufacturers of Ceftazidime-Avibactam (Avycaz/ Zavicefta)
Figure PHASE III DRUGS Product Picture
Table Major Manufacturers of PHASE III DRUGS
Table Global Antibacterial Drug Resistance Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Gram-Positive
Figure Gram-Negative
Figure Antibacterial Drug Resistance Report Years Considered
Figure Global Antibacterial Drug Resistance Market Size 2014-2025 (Million US$)
Figure Global Antibacterial Drug Resistance Sales 2014-2025 (K Units)
Table Global Antibacterial Drug Resistance Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antibacterial Drug Resistance Sales by Regions 2014-2019 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share by Regions 2014-2019
Figure Global Antibacterial Drug Resistance Sales Market Share by Regions 2014-2019
Figure 2018 Global Antibacterial Drug Resistance Sales Market Share by Regions
Table Global Antibacterial Drug Resistance Revenue by Regions 2014-2019 (Million US$)
Table Global Antibacterial Drug Resistance Revenue Market Share by Regions 2014-2019
Figure Global Antibacterial Drug Resistance Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antibacterial Drug Resistance Revenue Market Share by Regions
Table Global Antibacterial Drug Resistance Sales by Manufacturers (2014-2019) (K Units)
Table Global Antibacterial Drug Resistance Sales Share by Manufacturers (2014-2019)
Figure Global Antibacterial Drug Resistance Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antibacterial Drug Resistance Revenue by Manufacturers (2014-2019) (Million USD)
Table Antibacterial Drug Resistance Revenue Share by Manufacturers (2014-2019)
Figure Antibacterial Drug Resistance Value Share by Manufacturers in 2018
Table Key Manufacturers Antibacterial Drug Resistance Price (2014-2019) (USD/Unit)
Table Antibacterial Drug Resistance Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antibacterial Drug Resistance Product Type
Table Date of International Manufacturers Enter into Antibacterial Drug Resistance Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Global Antibacterial Drug Resistance Sales Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Sales Market Share by Product in 2018
Table Global Antibacterial Drug Resistance Revenue by Product (2014-2019) (Million US$)
Table Global Antibacterial Drug Resistance Revenue Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Revenue Market Share by Product (2014-2019)
Figure Global Antibacterial Drug Resistance Revenue Market Share by Product in 2018
Table Antibacterial Drug Resistance Price by Product 2014-2019 (USD/Unit)
Table Global Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Global Antibacterial Drug Resistance Sales Share by End User (2014-2019)
Figure Global Sales Antibacterial Drug Resistance Market Share by End User (2014-2019)
Figure Global Sales Antibacterial Drug Resistance Market Share by End User in 2018
Figure North America Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure North America Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table North America Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Sales Market Share by Countries
Table North America Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table North America Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Revenue Market Share by Countries
Figure United States Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure United States Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table North America Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Market Share by Product
Table North America Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table North America Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 North America Antibacterial Drug Resistance Market Share by End User
Figure Europe Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Europe Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Sales Market Share by Countries
Table Europe Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Europe Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Revenue Market Share by Countries
Figure Germany Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure France Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure UK Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Europe Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Market Share by Product
Table Europe Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Europe Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antibacterial Drug Resistance Market Share by End User
Figure Asia Pacific Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Sales Market Share by Countries
Table Asia Pacific Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Revenue Market Share by Countries
Figure China Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure China Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure India Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Market Share by Product
Table Asia Pacific Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antibacterial Drug Resistance Market Share by End User
Figure Central & South America Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Central & South America Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Sales Market Share by Countries
Table Central & South America Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Revenue Market Share by Countries
Figure Brazil Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Central & South America Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Market Share by Product
Table Central & South America Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Central & South America Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antibacterial Drug Resistance Market Share by End User
Figure Middle East and Africa Antibacterial Drug Resistance Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antibacterial Drug Resistance Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antibacterial Drug Resistance Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antibacterial Drug Resistance Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Sales Market Share by Countries
Table Middle East and Africa Antibacterial Drug Resistance Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antibacterial Drug Resistance Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Revenue Market Share by Countries
Figure GCC Countries Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antibacterial Drug Resistance Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antibacterial Drug Resistance Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antibacterial Drug Resistance Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antibacterial Drug Resistance Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Market Share by Product
Table Middle East and Africa Antibacterial Drug Resistance Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antibacterial Drug Resistance Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antibacterial Drug Resistance Market Share by End User
Table AAIPharma Services Company Details
Table AAIPharma Services Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AAIPharma Services Recent Development
Table ANTABIO Company Details
Table ANTABIO Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table ANTABIO Recent Development
Table Abgentis Company Details
Table Abgentis Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abgentis Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Laboratories Recent Development
Table Absynth Biologics Company Details
Table Absynth Biologics Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Absynth Biologics Recent Development
Table Achaogen Company Details
Table Achaogen Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Achaogen Recent Development
Table Acino Holdings Company Details
Table Acino Holdings Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Acino Holdings Recent Development
Table Aventis Pharma Company Details
Table Aventis Pharma Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Aventis Pharma Recent Development
Table Austell Laboratories Company Details
Table Austell Laboratories Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Austell Laboratories Recent Development
Table Assembly Biosciences Company Details
Table Assembly Biosciences Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Assembly Biosciences Recent Development
Table Arpida Company Details
Table Demuris Company Details
Table Evolva Holding Company Details
Table ContraFect Company Details
Table Cerexa Company Details
Table GSK Company Details
Table InterMune Company Details
Table Isis Pharmaceuticals Company Details
Table Lyndra Company Details
Table Microbecide Company Details
Table Morphochem Company Details
Table Nabriva Therapeutics Company Details
Table NanoSafe Coatings Company Details
Table Novexel Company Details
Table Osel Company Details
Table PENDOPHARM Company Details
Table Pfizer Company Details
Table VenatoRx Pharmaceuticals Company Details
Table Global Antibacterial Drug Resistance Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share Forecast by Regions 2019-2025
Table Global Antibacterial Drug Resistance Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antibacterial Drug Resistance Revenue Market Share Forecast by Regions 2019-2025
Table Global Antibacterial Drug Resistance Sales Forecast by Product 2019-2025 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share Forecast by Product 2019-2025
Table Global Antibacterial Drug Resistance Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antibacterial Drug Resistance Revenue Market Share Forecast by Product 2019-2025
Table Global Antibacterial Drug Resistance Sales Forecast by End User 2019-2025 (K Units)
Table Global Antibacterial Drug Resistance Sales Market Share Forecast by End User 2019-2025
Figure North America Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antibacterial Drug Resistance Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antibacterial Drug Resistance Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antibacterial Drug Resistance Value Chain
Table Antibacterial Drug Resistance Customers List
Table Antibacterial Drug Resistance Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"